Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Oricell Therapeutics Co., Ltd.”

3 pharma patents match "Oricell Therapeutics Co., Ltd." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 3 pharmaceutical patents matching "Oricell Therapeutics Co., Ltd." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3 results for “Oricell Therapeutics Co., Ltd.” · 30,257 patents in full index Clear search

  1. US 12054556

    Anti-PD-L1 antibody and use thereof

    Oricell Therapeutics Co., Ltd. · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  2. US 12005080

    Method for promoting proliferation of immune cells

    Oricell Therapeutics Co., Ltd. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  3. US 11993655

    Anti-PD-L1 antibody and use thereof

    Oricell Therapeutics Co., Ltd. · Granted May 28, 2024 · Expires May 23, 2044

    granted